Want to see JP:6171 full AI Analyst Report?
Top Page
C.E.Management Integrated Laboratory Co., Ltd.
(6171)
Select Model
Select Model
Rating:72Outperform
Price Target:
¥432.00
▲(3.60% Upside)
Action:Upgraded
Date:08/06/26
The score is driven primarily by solid financial fundamentals (low leverage and improved profitability) and strong valuation support (low P/E with a ~3.17% dividend yield). Technicals add a modest tailwind with positive momentum, but the overall rating is capped by inconsistent cash-flow conversion and the stock still being below its 200-day average.
Positive Factors
Conservative balance sheet
Very low leverage and a downward trend in debt-to-equity provide durable financial flexibility. A conservatively positioned balance sheet reduces refinancing risk, supports capex or M&A optionality, and helps the company weather sector cyclicality without compromising operations.
Negative Factors
Weak free cash flow coverage
FCF covering only ~0.53x of net income signals limited conversion of accounting profits into cash. This reduces internally available funds for capex, dividends, and strategic projects, increasing reliance on external financing despite low leverage and constraining financial optionality.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Very low leverage and a downward trend in debt-to-equity provide durable financial flexibility. A conservatively positioned balance sheet reduces refinancing risk, supports capex or M&A optionality, and helps the company weather sector cyclicality without compromising operations.
Read all positive factors
C.E.Management Integrated Laboratory Co., Ltd. (6171) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥5.42B
Dividend Yield3.15%
Average Volume (3M)191.95K
Price to Earnings (P/E)11.0
Beta (1Y)0.57
Revenue Growth8.08%
EPS Growth38.63%
CountryJP
Employees522
SectorGeneral
Sector StrengthN/A
IndustryEngineering & Construction
Share Statistics
EPS (TTM)39.92
Shares Outstanding14,237,995
10 Day Avg. Volume112,150
30 Day Avg. Volume191,953
Financial Highlights & Ratios
PEG Ratio0.37
Price to Book (P/B)1.15
Price to Sales (P/S)0.77
P/FCF Ratio23.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
C.E.Management Integrated Laboratory Co., Ltd. Business Overview & Revenue Model
Company Description
C.E.Management Integrated Laboratory Co.Ltd (CEMIL) is a Japanese company providing a broad spectrum of services for the civil engineering and construction sectors. Their offerings include detailed geological investigations to gather essential sub...
How the Company Makes Money
null...
C.E.Management Integrated Laboratory Co., Ltd. Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
78
Positive
Cash Flow
60
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.02B | 7.70B | 7.35B | 7.33B | 7.00B | 7.34B |
| Gross Profit | 3.10B | 2.84B | 2.87B | 2.74B | 2.65B | 2.53B |
| EBITDA | 1.15B | 973.45M | 919.26M | 739.14M | 921.58M | 801.64M |
| Net Income | 567.65M | 482.99M | 362.56M | 190.06M | 349.82M | 213.30M |
Balance Sheet | ||||||
| Total Assets | 7.32B | 7.35B | 7.03B | 6.86B | 7.01B | 6.99B |
| Cash, Cash Equivalents and Short-Term Investments | 2.35B | 2.22B | 2.27B | 2.14B | 1.75B | 1.81B |
| Total Debt | 589.31M | 612.19M | 671.35M | 840.94M | 1.10B | 1.04B |
| Total Liabilities | 2.05B | 2.18B | 2.16B | 2.23B | 2.44B | 2.63B |
| Stockholders Equity | 5.28B | 5.17B | 4.87B | 4.63B | 4.57B | 4.36B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 257.46M | 459.85M | 899.84M | 285.69M | 251.13M |
| Operating Cash Flow | 0.00 | 490.31M | 686.40M | 952.55M | 329.49M | 641.46M |
| Investing Cash Flow | 0.00 | -219.39M | -111.49M | -82.05M | 545.84M | -1.16B |
| Financing Cash Flow | 0.00 | -317.04M | -443.83M | -479.71M | -340.95M | 363.95M |
C.E.Management Integrated Laboratory Co., Ltd. Technical Analysis
Negative
417.00
Price Trends
381.13
Negative
387.09
Negative
409.21
Negative
Market Momentum
0.76
Negative
47.61
Neutral
28.79
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6171, the sentiment is Negative. The current price of 417 is above the 20-day moving average (MA) of 382.00, above the 50-day MA of 381.13, and above the 200-day MA of 409.21, indicating a bearish trend. The MACD of 0.76 indicates Negative momentum. The RSI at 47.61 is Neutral, neither overbought nor oversold. The STOCH value of 28.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6171.
C.E.Management Integrated Laboratory Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥92.25B | 13.31 | ― | 1.25% | 7.70% | 18.20% | |
72 Outperform | ¥5.42B | 10.96 | ― | 2.86% | 8.08% | 38.63% | |
69 Neutral | ¥26.81B | 10.95 | ― | 2.37% | 3.65% | 19.76% | |
66 Neutral | ¥4.16B | 4.01 | ― | 3.03% | 25.08% | 128.44% | |
65 Neutral | ¥15.46B | 8.15 | ― | 3.68% | -7.50% | 122.97% | |
63 Neutral | ¥7.72B | 13.99 | ― | 2.03% | 23.05% | 8.64% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
JP:6171
C.E.Management Integrated Laboratory Co., Ltd.
381.00
-58.63
-13.34%
JP:1914
Japan Foundation Engineering Co., Ltd.
733.00
92.66
14.47%
JP:4642
Original Engineering Consultants Co., Ltd.
1,425.00
-284.53
-16.64%
JP:4673
Kawasaki Geological Engineering Co., Ltd.
4,900.00
336.39
7.37%
JP:9621
CTI Engineering Co., Ltd.
3,160.00
251.33
8.64%
JP:9768
Idea Consultants,inc.
3,820.00
791.03
26.12%
C.E.Management Integrated Laboratory Co., Ltd. Corporate Events
C.E.Management Integrated Laboratory Posts Strong Q1 Earnings, Keeps Dividend Outlook Steady
May 18, 2026
C.E.Management Integrated Laboratory reported strong results for the three months ended March 31, 2026, with net sales rising 18.1% year on year to ¥2.14 billion and operating profit jumping 68.6% to ¥289 million. Profit attributable to ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.